Literature DB >> 24713984

Adrenocortical carcinoma: review and update.

Lori A Erickson1, Michael Rivera, Jun Zhang.   

Abstract

Adrenocortical carcinoma is a rare endocrine tumor with a poor prognosis. These tumors can be diagnostically challenging, and diagnostic algorithms and criteria continue to be suggested. Myxoid and oncocytic variants are important to recognize to not confuse with other tumors. In addition, the diagnostic criteria are different for oncocytic adrenal carcinomas than conventional carcinomas. Adrenocortical carcinomas usually occur in adults, but can also occur in children. In children these tumors are diagnostically challenging as the histologic features of malignancy seen in an adult tumor may not be associated with aggressive disease in a child. Adrenocortical carcinomas occur with increased frequency in Beckwith-Wiedemann and Li-Fraumeni syndromes, but most occur sporadically. Gene expression profiling by transcriptome analysis can discriminate adrenocortical carcinomas from adenomas and divide carcinomas into prognostic groups. The increasing understanding of the pathogenesis of these tumors may provide increasing treatment targets for this aggressive tumor.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24713984     DOI: 10.1097/PAP.0000000000000019

Source DB:  PubMed          Journal:  Adv Anat Pathol        ISSN: 1072-4109            Impact factor:   3.875


  13 in total

1.  Laparoscopic resection of giant adrenal malignant tumors, a case series and review of the literature.

Authors:  Konstantinos Sapalidis; Christoforos Kosmidis; Dimitrios Giannakidis; Varvara Fyntanidou; Anastasios Barmpas; Paul Zarogoulidis; Athanasios Katsaounis; Charilaos Koulouris; Nikolaos Michalopoulos; Aikaterini Amaniti; Zoi Aidoni; Stelian Mogoanta; Michael Karanikas; Panagoula Oikonomou; Konstantinos Romanidis; Anastasios Vagionas; Alexandru Marian Goganau; Alexandru Munteanu; Valeriou Surlin; Isaak Kesisoglou
Journal:  AME Case Rep       Date:  2020-01-20

2.  Ectopic, retroperitoneal adrenocortical carcinoma in the setting of Lynch syndrome.

Authors:  Jesse P Wright; Kathleen W Montgomery; Joshua Tierney; Jill Gilbert; Carmen C Solórzano; Kamran Idrees
Journal:  Fam Cancer       Date:  2018-07       Impact factor: 2.375

3.  Curative Surgical Resection of Adrenocortical Carcinoma: Determining Long-term Outcome Based on Conditional Disease-free Probability.

Authors:  Yuhree Kim; Georgios A Margonis; Jason D Prescott; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Jason A Glenn; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  Ann Surg       Date:  2017-01       Impact factor: 12.969

4.  Nomograms to Predict Recurrence-Free and Overall Survival After Curative Resection of Adrenocortical Carcinoma.

Authors:  Yuhree Kim; Georgios A Margonis; Jason D Prescott; Thuy B Tran; Lauren M Postlewait; Shishir K Maithel; Tracy S Wang; Douglas B Evans; Ioannis Hatzaras; Rivfka Shenoy; John E Phay; Kara Keplinger; Ryan C Fields; Linda X Jin; Sharon M Weber; Ahmed I Salem; Jason K Sicklick; Shady Gad; Adam C Yopp; John C Mansour; Quan-Yang Duh; Natalie Seiser; Carmen C Solorzano; Colleen M Kiernan; Konstantinos I Votanopoulos; Edward A Levine; George A Poultsides; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2016-04       Impact factor: 14.766

5.  Chloroquine alleviates etoposide-induced centrosome amplification by inhibiting CDK2 in adrenocortical tumor cells.

Authors:  T-Y Chen; J-S Syu; T-C Lin; H-L Cheng; F-L Lu; C-Y Wang
Journal:  Oncogenesis       Date:  2015-12-21       Impact factor: 7.485

6.  Lysosomal activity maintains glycolysis and cyclin E1 expression by mediating Ad4BP/SF-1 stability for proper steroidogenic cell growth.

Authors:  Jhih-Siang Syu; Takashi Baba; Jyun-Yuan Huang; Hidesato Ogawa; Chi-Han Hsieh; Jin-Xian Hu; Ting-Yu Chen; Tzu-Chien Lin; Megumi Tsuchiya; Ken-Ichirou Morohashi; Bu-Miin Huang; Fu-L Lu; Chia-Yih Wang
Journal:  Sci Rep       Date:  2017-03-21       Impact factor: 4.379

7.  Myxoid and Sarcomatoid Variants of Adrenocortical Carcinoma: Analysis of Rare Variants in Single Tertiary Care Center.

Authors:  Tae Yon Sung; Yun Mi Choi; Won Gu Kim; Yu Mi Lee; Tae Yong Kim; Young Kee Shong; Won Bae Kim; Dong Eun Song
Journal:  J Korean Med Sci       Date:  2017-05       Impact factor: 2.153

8.  Small Non-coding RNA Abundance in Adrenocortical Carcinoma: A Footprint of a Rare Cancer.

Authors:  Srinivas V Koduru; Ashley N Leberfinger; Dino J Ravnic
Journal:  J Genomics       Date:  2017-09-08

9.  A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study.

Authors:  Jianqiu Kong; Junjiong Zheng; Jinhua Cai; Shaoxu Wu; Xiayao Diao; Weibin Xie; Xiong Chen; Chenyi Liao; Hao Yu; Xinxiang Fan; Chaowen Huang; Zhuowei Liu; Wei Chen; Qiang Lv; Haide Qin; Jian Huang; Tianxin Lin
Journal:  Cancer Commun (Lond)       Date:  2019-11-27

10.  The construction and analysis of tumor-infiltrating immune cells and ceRNA networks in metastatic adrenal cortical carcinoma.

Authors:  Runzhi Huang; Ziqi Liu; Tingli Tian; Dianwen Song; Penghui Yan; Huabin Yin; Peng Hu; Xiaolong Zhu; Yihan Liu; Zhenyu Li; Tong Meng; Jie Zhang; Zongqiang Huang
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.